Browse: Departments   Dates   Agencies  

The Federal Register

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

CFR Citation: 21 CFR Part 558

NOTICE: RULES

ACTION: Animal drugs, feeds, and related products:

DOCUMENT ACTION: Final rule.

SUBJECT CATEGORY: New Animal Drugs for Use in Animal Feeds; Lasalocid and Bacitracin Methylene Disalicylate

DATES: This rule is effective September 5, 2001.

DOCUMENT SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Alpharma, Inc. The NADA provides for use of approved, singleingredient lasalocid and bacitracin methylene disalicylate Type A medicated articles to make twoway combination drug Type C medicated feeds. These combination medicated feeds are used for the prevention of coccidiosis, and for increased rate of weight gain and improved feed efficiency in growing turkeys.

SUMMARY: Lasalocid and bacitracin methylene disalicylate,


SUPPLEMENTAL INFORMATION

Alpharma, Inc., One Executive Dr., P.O. Box 1399, Fort Lee, NJ 07024, filed NADA 141179 that provides for use of AVATEC (90.7 grams per pound (g/lb) of lasalocid sodium) and BMD (50 g/lb of bacitracin methylene disalicylate) Type A medicated articles to make combination drug Type C medicated turkey feeds. The combination Type C medicated feeds are used for prevention of coccidiosis caused by Eimeria meleagrimitis, E. gallopavonis, E. adenoeides, and for increased rate of weight gain and improved feed efficiency in growing turkeys. The NADA is approved as of July 11, 2001, and the regulations are amended in 21 CFR 558.311 to reflect the approval. The basis of approval is discussed in the freedom of information summary.

In accordance with the freedom of information provisions of 21 CFR part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.

The agency has determined under 21 CFR 25.33(a)(2) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.

This rule does not meet the definition of ``rule'' in 5 U.S.C. 804(3)(A) because it is a rule of ``particular applicability.'' Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801808.
List of Subjects in 21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:

PART 558NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

1. The authority citation for 21 CFR part 558 continues to read as follows:

Authority: 21 U.S.C. 360b, 371.

2. Section 558.311 is amended in the table in paragraph (e)(1) by alphabetically adding an item under entry (xv) following ``Bacitracin 4 to 50'' to read as follows:
Sec. 558.311 Lasalocid.
* * * * *
(e) * * *
(1) * * *
Lasalocid sodium Combination
activity in in grams per Indications Limitations Sponsor grams per ton ton for use
* * * *
* * *
(xv) 68 (0.0075
pct) to 113
(0.0125 pct)
Bacitracin 4 * * * * * * * * * to 50
Bacitracin Growing Feed 046573 methylene turkeys; for continuously disalicylate prevention as sole
4 to 50 of ration.
coccidiosis Bacitracin caused by E. methylene
meleagrimiti disalicylate s, E. as provided gallopavonis by No.
, and E. 046573 in
adenoeides; Sec. 510.60 for 0(c) of this increased chapter.
rate of
weight gain
and improved
feed
efficiency.
* * * *
* * *
[[Page 46372]]
* * * * *

Dated: August 21, 2001.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 0122163 Filed 9401; 8:45 am] BILLING CODE 416001S

FOR FURTHER INFORMATION CONTACT Charles J. Andres, Center for Veterinary Medicine (HFV128), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 3018271600.


©2004,2005,2006 theFederalRegister.com